+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Renal Anemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767669
  • Report
  • April 2019
  • Region: Global
  • 236 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Akebia Therapeutics Inc
  • Amgen Inc
  • Astellas Pharma Inc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • FibroGen Inc
  • MORE
The global clinical trial report- “2019 Renal Anemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Renal Anemia. It presents in-depth analysis of Renal Anemia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Renal Anemia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Renal Anemia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Renal Anemia

The research work is prepared through extensive and continuous research on Renal Anemia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Renal Anemia patients are identified
  • The report includes panorama of Renal Anemia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Renal Anemia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Akebia Therapeutics Inc
  • Amgen Inc
  • Astellas Pharma Inc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • FibroGen Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Renal Anemia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Renal Anemia Clinical Trials by Region
2.2.2 Average Enrollment of Renal Anemia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Renal Anemia Treatment, 2019

3. Region wise Renal Anemia Clinical Trials
3.1 Asia Pacific Renal Anemia Clinical Trials by Country
3.2 Europe Renal Anemia Clinical Trials by Country
3.3 North America Renal Anemia Clinical Trials by Country
3.4 Middle East and Africa Renal Anemia Clinical Trials by Country
3.5 South and Central America Renal Anemia Clinical Trials by Country

4. Renal Anemia Clinical Trial Trends
4.1 Start Year wise Renal Anemia Clinical Trials
4.2 Phase wise Renal Anemia Clinical Trials
4.3 Trial Status wise Renal Anemia Clinical Trials
4.4 Trial Type wise Renal Anemia Clinical Trials

5. Renal Anemia Average Enrollment Trends
5.1 Average Enrollment in Renal Anemia Trials by Year
5.2 Average Enrollment in Renal Anemia Trials by Phase
5.3 Average Enrollment in Renal Anemia Trials by Status
5.4 Average Enrollment in Renal Anemia Trials by Type of Trial

6. Companies Participating in Renal Anemia Clinical Trials
6.1 Renal Anemia Trials by Sponsor Type
6.2 Renal Anemia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Renal Anemia Trials- Phase 1
7.2 Renal Anemia Trials- Phase 2
7.3 Renal Anemia Trials- Phase 3
7.4 Renal Anemia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Renal Anemia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Renal Anemia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Renal Anemia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Renal Anemia Clinical Trials and Enrolment
Figure 7: North America - Country wise Renal Anemia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Renal Anemia Clinical Trials and Enrolment
Figure 9: Renal Anemia Clinical Trials by Phase
Figure 10: Renal Anemia Clinical Trials by Trial Status
Figure 11: Renal Anemia Clinical Trials by Type
Figure 12: Renal Anemia Clinical Trials by Sponsor Type
Figure 13: Renal Anemia Clinical Trials by Leading Sponsors
Figure 14: Renal Anemia Average Enrollment by Phase
Figure 15: Renal Anemia Average Enrollment by Trial Status
Figure 16: Renal Anemia Average Enrollment by Type
Figure 17: Renal Anemia- Average Enrolment by Type of Sponsors
Figure 18: Renal Anemia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Renal Anemia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Renal Anemia Clinical Trials and Enrolment
Table 5: Europe - Country wise Renal Anemia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Renal Anemia Clinical Trials and Enrolment
Table 7: North America - Country wise Renal Anemia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Renal Anemia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Renal Anemia Average Enrollment by Phase
Table 15: Renal Anemia Average Enrollment by Trial Status
Table 16: Renal Anemia Average Enrollment by Type
Table 17: Renal Anemia- Average Enrolment by Type of Sponsors
Table 18: Renal Anemia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Akebia Therapeutics Inc
  • Amgen Inc
  • Astellas Pharma Inc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • FibroGen Inc
  • GlaxoSmithKline Plc
  • Japan Tobacco Inc
  • Pfizer Inc
  • Takeda Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll